BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24066888)

  • 1. Structural vaccinology: a three-dimensional view for vaccine development.
    Cozzi R; Scarselli M; Ferlenghi I
    Curr Top Med Chem; 2013; 13(20):2629-37. PubMed ID: 24066888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural vaccinology starts to deliver.
    Dormitzer PR; Grandi G; Rappuoli R
    Nat Rev Microbiol; 2012 Dec; 10(12):807-13. PubMed ID: 23154260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccine design using reverse and structural vaccinology, ontology-based literature mining and machine learning.
    Huffman A; Ong E; Hur J; D'Mello A; Tettelin H; He Y
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design.
    Rappuoli R; Bottomley MJ; D'Oro U; Finco O; De Gregorio E
    J Exp Med; 2016 Apr; 213(4):469-81. PubMed ID: 27022144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of structural proteomics in vaccine development: recent advances and future prospects.
    Donnarumma D; Faleri A; Costantino P; Rappuoli R; Norais N
    Expert Rev Proteomics; 2016; 13(1):55-68. PubMed ID: 26714563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two meanings of reverse vaccinology and the empirical nature of vaccine science.
    Van Regenmortel MH
    Vaccine; 2011 Oct; 29(45):7875. PubMed ID: 21888936
    [No Abstract]   [Full Text] [Related]  

  • 7. [Application of the branched multiple antigenic peptide system in the development of vaccine].
    Liu XY; Zhang ZQ
    Bing Du Xue Bao; 2011 Jan; 27(1):86-90. PubMed ID: 21462513
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure and Computation in Immunoreagent Design: From Diagnostics to Vaccines.
    Gourlay L; Peri C; Bolognesi M; Colombo G
    Trends Biotechnol; 2017 Dec; 35(12):1208-1220. PubMed ID: 28739221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy.
    Saylor K; Gillam F; Lohneis T; Zhang C
    Front Immunol; 2020; 11():283. PubMed ID: 32153587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from Reverse Vaccinology for viral vaccine design.
    Bruno L; Cortese M; Rappuoli R; Merola M
    Curr Opin Virol; 2015 Apr; 11():89-97. PubMed ID: 25829256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome- and proteome-wide screening strategies for antigen discovery and immunogen design.
    Schussek S; Trieu A; Doolan DL
    Biotechnol Adv; 2014; 32(2):403-14. PubMed ID: 24389084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases.
    Lew-Tabor AE; Rodriguez Valle M
    Ticks Tick Borne Dis; 2016 Jun; 7(4):573-85. PubMed ID: 26723274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonclassically secreted proteins as possible antigens for vaccine development: a reverse vaccinology approach.
    de Alvarenga Mudadu M; Carvalho V; Leclercq SY
    Appl Biochem Biotechnol; 2015 Apr; 175(7):3360-70. PubMed ID: 25672322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward rational vaccine engineering.
    Vishweshwaraiah YL; Dokholyan NV
    Adv Drug Deliv Rev; 2022 Apr; 183():114142. PubMed ID: 35150769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines based on structure-based design provide protection against infectious diseases.
    Thomas S; Luxon BA
    Expert Rev Vaccines; 2013 Nov; 12(11):1301-11. PubMed ID: 24090172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines.
    Moise L; Gutierrez A; Kibria F; Martin R; Tassone R; Liu R; Terry F; Martin B; De Groot AS
    Hum Vaccin Immunother; 2015; 11(9):2312-21. PubMed ID: 26155959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse vaccinology.
    Mora M; Veggi D; Santini L; Pizza M; Rappuoli R
    Drug Discov Today; 2003 May; 8(10):459-64. PubMed ID: 12801798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinology at the beginning of the 21st century.
    Wack A; Rappuoli R
    Curr Opin Immunol; 2005 Aug; 17(4):411-8. PubMed ID: 15950445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of Bm86 gene orthologs from Hyalomma excavatum, Hyalomma dromedarii and Hyalomma marginatum marginatum and comparison with a vaccine candidate from Hyalomma scupense.
    Ben Said M; Galai Y; Mhadhbi M; Jedidi M; de la Fuente J; Darghouth MA
    Vet Parasitol; 2012 Nov; 190(1-2):230-40. PubMed ID: 22683299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing the next generation of vaccines for global public health.
    Bagnoli F; Baudner B; Mishra RP; Bartolini E; Fiaschi L; Mariotti P; Nardi-Dei V; Boucher P; Rappuoli R
    OMICS; 2011 Sep; 15(9):545-66. PubMed ID: 21682594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.